Using surrogate failure time data to increase cost effectiveness in clinical trials (Q4299462): Difference between revisions
From MaRDI portal
Added link to MaRDI item. |
Set OpenAlex properties. |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Property / author | |||
| Property / author: Thomas R. Fleming / rank | |||
| Property / author | |||
| Property / author: Thomas R. Fleming / rank | |||
Normal rank | |||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.1093/biomet/80.4.823 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W1972164191 / rank | |||
Normal rank | |||
Latest revision as of 21:59, 19 March 2024
scientific article; zbMATH DE number 600057
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Using surrogate failure time data to increase cost effectiveness in clinical trials |
scientific article; zbMATH DE number 600057 |
Statements
Using surrogate failure time data to increase cost effectiveness in clinical trials (English)
0 references
4 July 1994
0 references
asymptotic joint distribution
0 references
censored data
0 references
failure times
0 references
linear rank statistic
0 references
martingale
0 references
multiple endpoints
0 references
surrogate outcome
0 references
weighted log rank
0 references
